Table 1.
Blood sampling data
| Reference range | 21 weeks | 28 weeks | 35-4/7 weeks | 35-5/7weeks 9 a.m. /5 p.m. |
Pre-operative (35-6/7) 1 a.m. |
Post-operative | POD 4 | POD 7 | POD 62 | Post-operative 1 year | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T-Bil (mg/dL) | 0.2–1.2 | 1.2 | 1.3 | 4.6 | 5.7/NE | NE | 3.6 | 13.5 | 19.0 | 4.6 | 0.9 |
| ALT (U/L) | 6–30 | 214 | 29 | 41 | 44/NE | NE | 23 | 28 | 28 | 16 | 20 |
| ALB (g/dL) | 3.8–5.1 | 3.5 | NE | NE | 2.2/NE | NE | 2.2 | 3.2 | 3.5 | 3.5 | 4.1 |
| NH3 (μ/dL) | 12–66 | NE | NE | NE | 132/NE | NE | NE | 70 | 65 | 56 | NE |
| Cre (mg/dL) | 0.48–0.79 | 0.38 | 0.44 | 0.63 | 0.68/NE | NE | 0.62 | 0.60 | 2.29 | 0.51 | 0.53 |
| UA (mg/dL) | 2.4–5.9 | 2.6 | NE | NE | NE/NE | NE | 3.8 | 1.8 | NE | NE | 3.6 |
| PT (%) | 70–130 | 90.9 | NE | 31.6 | 29.1/27.0 | 56.7 | 47.3 | 29.3 | 37.0 | 56.0 | NE |
| APTT (sec) | 25.5–39.5 | 34.6 | NE | NE | NE/64.2 | 42.0 | 61.2 | > 150 | 42.9 | NE | NE |
| AT-III (%) | 80–130 | NE | NE | NE | NE/< 10 | 99 | 60 | 52 | 88 | NE | NE |
| Fib (mg/dL) | 150–350 | NE | NE | NE | NE/< 50 | 142 | 146 | 199 | 185 | NE | NE |
| WBC (/μL) | 4000–8600 | 8050 | 7950 | 9330 | 10,180/7310 | 6000 | 5950 | 11,290 | 18,480 | 1880 | 2320 |
| Hb (g/dL) | 12.0–16.0 | 11.7 | 10.1 | 11.1 | 11.7/9.4 | 8.8 | 7.4 | 9.1 | 9.3 | 10.5 | 8.4 |
| PLT (K/μL) | 150–350 | 167 | 165 | 62 | 59/50 | 37 | 52 | 75 | 35 | 41 | 66 |
NE not examined, T-Bil total bilirubin, ALT alanine aminotransferase, ALB albumin, NH3 ammonia, Cre creatinine, UA uric acid, PT prothrombin time, APTT activated partial thromboplastin time, AT-III antithrombin, Fib fibrinogen, WBC white blood cell, Hb hemoglobin, PLT platelet count